Serious adverse events in patients treated with new oral anticoagulants are underreported.
The study investigates if serious adverse events in patients treated with NOAC are reported to the Health and Medicines Authority.
Study Type
OBSERVATIONAL
Enrollment
20
Hvidovre Hospital University of Copenhagen
Hvidovre, Denmark
Proportion of patients admitted with adverse event reported to authorities
Time frame: Within one year of admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.